A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) (Q63062120)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A Placebo Controlled 4 Week Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (RO-2351-001-EM) |
clinical trial |
Statements
A Proof of Concept Study With 0.5% Roflumilast Cream in Patients With Mild Atopic Dermatitis (English)
0 references
November 2008
0 references
June 2009
0 references
0
0 references
18 year
0 references
65 year
0 references